restor3d closes $70 million funding round

restor3d, a company specializing in personalized 3D printed orthopedic implants, has closed a $55 million Series A funding round – led by private investors including Summers Value Partners and existing investors – and an additional $15 million in debt financing led by Trinity Capital. This significant investment will accelerate the company’s growth and innovation in several key areas.

Consistent with the company’s mission to deliver novel, personalized medical solutions, restor3d will introduce new patient-specific implant systems for total ankle and shoulder replacements. These innovative systems will offer 3D printed solutions that fit the unique anatomy and pathology of individual patients. In the patient-specific hip and knee portfolios, the company will continue to make product advancements including a porous press-fit knee enabled by 3D printing of both the tibial and femoral components.

Continued investments in novel 3D printing technologies will expand restor3d’s rapid in-house ‘powder to sterile product’ production environment – providing the capacity to grow the business for many years to come. In addition to providing capacity, these investments will also shorten personalized implant delivery times while simultaneously reducing production costs.

To decrease lead times and support continued high growth, restor3d will continue investments in cutting-edge software and design automation solutions. These advancements will speed up case intake and design processes, reduce digital design times, and improve service levels to surgeons and their patients.

The new funding will also enable the expansion of restor3d’s educational initiatives, providing surgeons and sales teams with comprehensive training on the latest technologies and surgical techniques in orthopedic and reconstructive surgery.

“This fundraising round is a testament to the confidence our investors have in restor3d’s vision and potential,” said Kurt Jacobus, CEO of restor3d. “With this capital, we can accelerate our efforts to transform orthopedic care through 3D printed personalized implants. We are eager to maximize our impact on patient outcomes and continue to advance of orthopedic care. We are grateful for the support from our investors and look forward to a future of continued growth and success.”